Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02803164
Other study ID # 16-002486
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 10, 2017
Est. completion date November 3, 2020

Study information

Verified date September 2021
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Vacuum-assisted dressings (V-AD) are effective in treating patients with open chest wounds (OCW) and will decrease the time-to-closure of such wounds when compared to a historical cohort of patients managed by traditional wound care management.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date November 3, 2020
Est. primary completion date November 3, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Subject is scheduled to undergo surgical intervention(s) as part of the standard care for management of intra-thoracic infection. Exclusion Criteria: - Patent bronchopleural fistulas. Severe respiratory failure requiring mechanical ventilation at the time of first consultation. - Proven or suspected malignancy in the wound. Coagulopathy due to medical or pharmacologic reasons. Dependency on anticoagulants or antiplatelet medication due to high risk for adverse events if these medications are stopped for a prolonged period of time. Allergy to acrylic products.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Wound Vacuum-assisted dressing
The NPWT system (V.A.C. Therapy System, KCI USA Inc.) consisted of a medical-grade non-adherent polyvinyl alcohol white foam applied directly to the infected surface, followed by an open-pore reticulated polyurethane black foam cut to fit the wound and covered by a transparent air-tight adhesive drape. A suction cup with tubing was placed over a small slit on the drape and connected to a suction machine (V.A.C. ULTA Therapy Unit).
Other:
Control group
Retrospective review of subjects medical records with open chest wounds who were treated with the traditional treatment techniques.

Locations

Country Name City State
United States Mauricia Buchanan Jacksonville Florida

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Duration of Negative Pressure Wound Therapy (NWPT) The total number of days of receiving NWPT 12 month follow up
Secondary Wound Closure The total number of days to wound closure 12 months
Secondary Length of Hospital Stay The total number of days in hospital 12 months